Cytosorbents Crp (CTSO)

Cytosorbents Crp (CTSO) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.2M; returns 1 day -12.3%, 1 week +28.2%, 1 year -68.7%.

CytoSorbents Corporation (CTSO) is a leader in blood purification therapies for life-threatening conditions treated in intensive care units and cardiac surgery. Its core product, CytoSorb, is approved in the European Union and available in over 70 countries worldwide. The company is also working to gain U.S.

Groups CTSO belongs to

• Healthcare
• Recent Reverse Splits
• Medical Devices
• Healthcare Equipment
• Life Sciences
• Commercial Stage

CTSO financial model: income statement, cash flow and balance sheet